QHP Capital Announces Investment in Vector Clinical Trials, Partnering with Founder Dr. Bobby Mocherla to Scale Community-Focused Research Sites

Audio By Carbonatix

RALEIGH, N.C. & LAS VEGAS--(BUSINESS WIRE)--Sep 30, 2025--

QHP Capital (“QHP”) today announced an investment in Vector Clinical Trials (“Vector” or the “Company”), a leading clinical research site network led by Founder Dr. Bobby Mocherla.

The partnership is designed to accelerate Vector’s growth while preserving the qualities that have made the Company so successful to date – an unwavering focus on high-quality research that integrates into the physician and patient communities Vector serves, combining superior patient experience with high-velocity, representative enrollment.

“Vector’s model starts with the community,” said Michael Sorensen, Partner at QHP Capital. “By partnering with physicians where patients already receive care, Vector consistently delivers speed, quality, and access – especially for populations historically underrepresented in research. We’re excited to back Dr. Bobby and invest behind building sites with real scale that serve their communities while meeting sponsors’ enrollment and data-quality needs.”

“Our mission is to bring clinical research to patients where they are,” said Dr. Bobby Mocherla, Founder of Vector Clinical Trials. “QHP shares our patient-first philosophy and brings the pharma services expertise to help us expand responsibly – improving access, delivering high-performance enrollment across all demographics, and supporting our partners with best-in-class clinical operations.”

Cantor Fitzgerald served as financial advisor to Vector.

About Vector Clinical Trials

Vector Clinical Trials is a dedicated clinical research site network with headquarters in Las Vegas, NV and a recently launched site in Reno, NV. For more information, please visit www.vectorclinicaltrials.com.

About QHP Capital

Based in the Research Triangle Park of North Carolina, QHP Capital invests in life sciences and pharma services companies with proven products, services, and enabling technologies, utilizing a strategic platform to source, diligence, and create value. Led by a senior team of investment, healthcare, and research professionals, and rooted in the legacy of Quintiles (now IQVIA) and NovaQuest, QHP seeks to partner with founders and management teams to create long-term value. QHP Capital is the management company for NovaQuest Private Equity. For more information, please visit www.qhpcapital.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250930460251/en/

CONTACT: Media Contact

Silvia Cruz

(919) 261-5266

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA NORTH CAROLINA NEVADA

INDUSTRY KEYWORD: SCIENCE RESEARCH PHARMACEUTICAL FINANCE HEALTH BANKING PROFESSIONAL SERVICES CLINICAL TRIALS

SOURCE: QHP Capital

Copyright Business Wire 2025.

PUB: 09/30/2025 09:00 AM/DISC: 09/30/2025 09:02 AM

http://www.businesswire.com/news/home/20250930460251/en